Ken retweeted
You Are Invited!
🚀 I am excited to invite everyone to join the @UTHeartVascular Heart & Vascular faculty and fellows at #TCT2026 in San Diego! Nov 1–3 🌴
We’ll be diving into CTOs, calcium management, MCS, shock, structural interventions, and more! 😀
Come find us, say hi, and let’s learn together! #TCT2026 @UTHealthHouston
🤖 Made with AI
After a quick review session with our research team and APP fellows, I decided to build a visual aid for teaching. With @claudeai, I just keep adding more content and it feels limitless—now I just have to patiently wait for my usage limit to refresh 🤓
lubdubappguide.com/
Ken retweeted
#TCACC26 Southern FIT Jeopardy session, with @UTHeartVascular as the winner! So proud of our fellows winning the semi finals!!
Ken retweeted
This daycare in Minnesota receives the most amount of money from the government at a staggering $3,670,000 in CCAP funding (tax exempt), yet they can’t even give you a paper to enroll your child.
One top of the daycare fraud you also have an autism center fraud, these “centers” have EXPONENTIALLY increased over the years in 2024 $228,092,998 was allocated for autism Medicaid.
Tim Walz is yet to say anything, accountability for him and the fraudsters must happen.
Ken retweeted
What an amazing start to #TCT25! In just the first two days, our @UTHeartVascular team presented 3 cases and 9 abstracts. So proud of this talented group and all we’ve accomplished — and we’re not done yet! More sessions from our presenters in the next two days, so stay tuned!
Ken retweeted
Dr Abhijeet Dhoble presented long term outcomes of TAVR in bicuspid aortic valves based on morphology
#TCT2025 #tavr
@UTHeartVascular
@Dhoble7
Ken retweeted
Dr Salman Arain on the big stage presenting #HDR !
#TCT2025 #CTO
@UTHealthHouston
@UTHeartVascular
@realarainmd
Ken retweeted
Several @UTHealthHouston heart experts will present at this year's TCT 2025 conference, Oct. 25-28 in San Francisco. This year’s conference will highlight the power of acute interventions, with a focus on lifesaving procedures, breakthrough tech, and cutting-edge research.
Ken retweeted
TMVR ViV in prior 25 mm Epic valve, Fracking performed with 24 mm Balloon, expanding the valve reasonably well. @memorialhermann @UTHeartVascular
Ken retweeted
The Contrast Modulation revolution is here! I made this account to spread the word and share my experiences with this exciting and often misunderstood technique. It is NOT an alternative to conventional CTO PCI - but an adjunct. Please comment, critique, share! #contrast1st #HDR
Ken retweeted
Wow, it is now illegal to require voter ID in California!
They just made PREVENTING voter fraud against the law.
The Joker is in charge.
NEWS: California enacts law banning voter ID requirements
Governor Gavin Newsom signed a bill into law that bars local governments from enacting laws to require residents to show a valid form of identification in order to vote.
democracydocket.com/news-ale…
Ken retweeted
🔥Hot off the press🔥 Read our simultaneous publication in #StructuralHeart🫀 @crfshj at #NYValves2024 @crfheart
💥Free access here: structuralheartjournal.org/p…
💥Similar VARC-3 outcomes with #Navitor and #Evolut in small annulus
@IbrahimSultanMD @DSGMD
@HviUpmc @UPMC_CTSurgery
📢 Simultaneously published and presented today by @M_Pompeu_Sa_MD at #NYValves2024! 🌟 Results from a propensity-score matched study examining #TAVR outcomes between supra-annular and intra-annular self-expanding valves. 🔍💡#CardioTwitter #CardioX structuralheartjournal.org/p…
Ken retweeted
A group of pediatricians, medical organizations, and policy organizations have signed a declaration urging a stop to the promotion of harmful interventions on children with gender dysphoria.
Comment and repost if you agree! Then sign the declaration at doctorsprotectingchildren.or…
Ken retweeted
Diagnosis of #HFpEF in pts w/ #AFib: HFA-PEFF and H2FPEF scores demonstrated moderate accuracy. (HFA-PEFF AUC 0.633, H2FPEF AUC 0.707). These data suggest invasive hemodynamic diagnosis of HFpEF is the gold standard in this cohort bit.ly/4bNbteT #JACCHF
Ken retweeted
#Ertugliflozin for Functional #MR Associated With #HeartFailure: #EFFORT Trial
📍Ertugliflozin significantly reduced effective regurgitant orifice area
📍Regurgitant volume decreased by 11.2 mL(P=0.009)
📍#LAVI decreased by 6.0 mL/m2 (P=0.005)
📍LV GLS reduced by 1.44% (P=0.004)
📍Serious adverse events were minimal
ahajournals.org/doi/10.1161/…
@CircAHA #SGLT2i
